![](/img/cover-not-exists.png)
PCN34 COST-EFFECTIVENESS OF ANASTROZOLE OVERTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER FROM A UK NATIONAL HEALTH SERVICE PERSPECTIVE: THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL
R Brown, A Benedict, R ManselVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)67272-5
File:
PDF, 81 KB
english, 2005